Association of loss of heterozygosity with cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 7, 2008, Pages 610-614

  Pinheiro, R F ^a   Serio, F M ^a   Silva, M R R ^a   Briones, M R S ^a   Chauffaille, M L L F ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute myeloid leukemia; Cytogenetic abnormalities; Loss of heterozygosity; Myelodysplastic syndrome

Indexed keywords

INTERFERON REGULATORY FACTOR 1;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME 5Q; CHROMOSOME 7Q; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; INTRON; KARYOTYPING; MICROSATELLITE MARKER; MYELODYSPLASTIC SYNDROME;

EID: 52949130273     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008000700010     Document Type: Article

References (13)

1. Loeb LA, Springgate CF, Battula N. Errors in DNA replication as a basis of malignant changes. Cancer Res 1974; 34: 2311-2321.
2. Krskova-Honzatkova L, Cermak J, Sajdova J, Stary J, Sedlacek P, Sieglova Z. Loss of heterozygosity and heterogeneity of its appearance and persisting in the course of acute myeloid leukemia and myelodysplastic syndromes. Leuk Res 2001; 25: 45-53.
3. List AF, Vardiman J, Issa JP, DeWitte TM. Myelodysplastic syndromes. Hematol Am Soc Hematol Educ Program 2004; 297-317.
4. Chauffaille ML, Yamamoto M, Moncau JE, Braga GW, Souto EX, Kerbauy J. Cytogenetic abnormalities as prognostic factors in acute myeloid leukemia. Rev Assoc Med Bras 1996; 42: 200-204.
5. Shaffer LG, Tommerup N (Editors). ISCN (2005): An international system for human cytogenetic nomenclature. Basel: S. Karger Publishers; 2005.
6. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
7. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322-2333.
8. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
9. Lee TH, Sakahara NS, Fiebig EW, Hirschkorn DF, Johnson DK, Busch MP. Quantitation of white cell subpopulations by polymerase chain reaction using frozen whole-blood samples. Viral Activation Transfusion Study. Transfusion 1998; 38: 262-270.
10. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR, Quirke P. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 1993; 67: 1262-1267.
11. Koike M, Tasaka T, Spira S, Tsuruoka N, Koeffler HP. Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.1 (D7S486) and q33-34 (D7S498, D7S505). Leuk Res 1999; 23: 307-310.
12. Basirico R, Pirrotta R, Fabbiano F, Mirto S, Cascio L, Pagano M, et al. Submicroscopic deletions at 7q region are associated with recurrent chromosome abnormalities in acute leukemia. Haematologica 2003; 88: 429-437.
13. Liebermann DA, Hoffman B. Myeloid differentiation (MyD) primary response genes in hematopoiesis. Oncogene 2002; 21: 3391-3402.